Common mild side effects across GLP-1 medications include: Nausea, particularly during early weeks and dose increases Vomiting Diarrhea or constipation Injection site reactions Decreased appetite These effects are most pronounced early in treatment and typically lessen as the body adjusts
Tirzepatide drugs like Zepbound continue to cause severe injuries, like vision loss, pancreatitis, blood clots, and a range of serious gastrointestinal injuries, in some patients
Yigla M, Tov N, Solomonov A, Rubin AHE, Harlev D
doi: 10.1242/dmm.006775
despite the blood glucose target set of this HCL system is off label
Gastric bypass can have a strong metabolic effect and may be considered for patients with type 2 diabetes, but the best option depends on the patients full medical history and should be discussed with a bariatric surgeon